Stephen Feinberg

CIK 947822 · last filed 2025-02-11

Stephen Feinberg is a corporate insider who has filed 90 SEC Form 4 insider transactions across 17 companies since 2007. The most recent filing, for ACI, was dated Feb 11, 2025. Across all open-market trades the lifetime net is −$883.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.20B across reported positions. 22 SEC filings were submitted jointly with KINDRED HEALTHCARE, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$2.20B
Companies
17
Total Filings
90
Lifetime Open-Market Net
-$883.80M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

TLCR price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
875 THIRD AVENUE
11TH FLOOR
NEW YORK, NY 10022
State of Incorporation
NY
Related Filers
KINDRED HEALTHCARE, INC — 22 joint filings, latest 2004-11-17
RETAIL VENTURES INC — 9 joint filings, latest 2008-02-12
Cerberus Telecom Acquisition Holdings, LLC — 5 joint filings, latest 2021-09-30
EXCO RESOURCES INC — 4 joint filings, latest 2003-03-24
Winthrop Realty Trust — 2 joint filings, latest 2004-08-26
Danaos Corp — 1 joint filings, latest 2018-12-17
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACI Director 151,818,680 $12.91 $1.96B $0 2 2025-02-11
Cerberus Telecom Acquisition Corp. (CTAC.WS) Delisted Director — $1.00 — $0 1 2021-09-30
Cerberus Telecom Acquisition Corp. (CTAC.U) Delisted Director 800,000 $8.18 $6.54M $0 2 2020-12-07
ATEX 10%+ Owner 1,701,599 $80.78 $137.46M -$48.16M 2 2019-10-15
Anterix Inc. (PDVW) Delisted 10%+ Owner 2,887,407 — — $25.52M 27 2019-06-13
BXC 10%+ Owner 270,398 $65.16 $17.62M $27.02M 3 2017-10-23
BLBD 10%+ Owner 0 $60.32 $0 -$125.70M 2 2016-06-10
AVON PRODUCTS INC (AVP) Delisted 10%+ Owner — — — $0 1 2016-04-04
Tower International, Inc. (TOWR) Delisted 10%+ Owner 1,579,744 — — -$229.00M 2 2013-11-08
DIGITALGLOBE, INC. (DGI) Delisted 10%+ Owner 5,486,429 — — -$141.50M 1 2013-03-11
GeoEye, Inc. (GEOY) Delisted 10%+ Owner 4,772,179 — — $92.04M 26 2012-08-09
Hawaiian Telcom Holdco, Inc. (HCOM) Delisted 10%+ Owner 840,442 $14.54 $12.22M -$297.5K 1 2011-09-09
BIOSPHERE MEDICAL INC (BSMD) Delisted 10%+ Owner 2,763,268 — — $0 2 2010-09-08
SSTI 10,762,583 $8.32 $89.54M $0 1 2010-03-26
Talecris Biotherapeutics Holdings Corp. (TLCR) Delisted 10%+ Owner 61,175,236 — — -$485.73M 1 2009-10-07
SCOTTISH RE GROUP LTD (SCT) Delisted 10%+ Owner — — — $0 1 2007-06-07
Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted 10%+ Owner 3,753,306 — — $2.01M 8 2007-04-10

Recent Filings

90 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-02-11 ACI Grant (A) — $0 EDGAR
2024-11-05 ACI Grant (A) — $0 EDGAR
2021-09-30 Cerberus Telecom Acquisition Corp. (CTAC.WS) Delisted Disp (D) — $0 EDGAR
2020-12-07 Cerberus Telecom Acquisition Corp. (CTAC.U) Delisted Disp (D) — $0 EDGAR
2020-10-28 Cerberus Telecom Acquisition Corp. (CTAC.U) Delisted Grant (A) +800,000 $8.00M EDGAR
2019-10-15 ATEX Sell (S) −115,000 -$4.66M EDGAR
2019-09-03 ATEX Sell (S) −1,000,000 -$43.50M EDGAR
2019-06-13 Anterix Inc. (PDVW) Delisted Sell (S) −72,843 -$3.57M EDGAR
2019-06-04 Anterix Inc. (PDVW) Delisted Sell (S) −139,413 -$6.73M EDGAR
2019-05-30 Anterix Inc. (PDVW) Delisted Sell (S) −477,602 -$23.83M EDGAR
Showing 1–10 of 90
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.